Alliance Pharma (LSE:APH) Pre-Tax Income : £-5.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Alliance Pharma's pretax income for the six months ended in Jun. 2023 was £6.2 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was £-5.0 Mil. Alliance Pharma's pretax margin was 7.66%.

During the past 13 years, Alliance Pharma's highest Pretax Margin was 31.40%. The lowest was -2.96%. And the median was 22.85%.

Alliance Pharma Pre-Tax Income Historical Data

The historical data trend for Alliance Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Pre-Tax Income Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pre-Tax Income

Get a 7-Day Free Trial

22.80

31.08

13.02

18.16

5.21

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial															16.52	1.64	16.48	-11.27	6.24

Competitive Comparison of Alliance Pharma's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Pre-Tax Income falls into.

Alliance Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Alliance Pharma's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	28.803	+	0	+	-4.785	+	0.016	+	-18.826
	=	5.2

Alliance Pharma's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	13.195	+	0	+	-4.279	+	0	+	-2.68
	=	6.2

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-5.0 Mil.

Alliance Pharma (LSE:APH) Pre-Tax Income Explanation

Alliance Pharma's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	6.236	/	81.398
	=	7.66%

During the past 13 years, Alliance Pharma's highest Pretax Margin was 31.40%. The lowest was -2.96%. And the median was 22.85%.

Alliance Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).